Remove tag click-therapeutics
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Anti-obesity therapeutic landscape. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1% Uzbekistan.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Anti-obesity therapeutic landscape. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1% Uzbekistan.

Medical 98